<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36693071</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020.</ArticleTitle><Pagination><StartPage>e0280990</StartPage><MedlinePgn>e0280990</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0280990</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0280990</ELocationID><Abstract><AbstractText Label="BACKGROUND">The World Health Organization declared a pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on March 11, 2020. The standardized approach of disability-adjusted life years (DALYs) allows for quantifying the combined impact of morbidity and mortality of diseases and injuries. The main objective of this study was to estimate the direct impact of COVID-19 in France in 2020, using DALYs to combine the population health impact of infection fatalities, acute symptomatic infections and their post-acute consequences, in 28 days (baseline) up to 140 days, following the initial infection.</AbstractText><AbstractText Label="METHODS">National mortality, COVID-19 screening, and hospital admission data were used to calculate DALYs based on the European Burden of Disease Network consensus disease model. Scenario analyses were performed by varying the number of symptomatic cases and duration of symptoms up to a maximum of 140 days, defining COVID-19 deaths using the underlying, and associated, cause of death.</AbstractText><AbstractText Label="RESULTS">In 2020, the estimated DALYs due to COVID-19 in France were 990 710 (1472 per 100 000), with 99% of burden due to mortality (982 531 years of life lost, YLL) and 1% due to morbidity (8179 years lived with disability, YLD), following the initial infection. The contribution of YLD reached 375%, assuming the duration of 140 days of post-acute consequences of COVID-19. Post-acute consequences contributed to 49% of the total morbidity burden. The contribution of YLD due to acute symptomatic infections among people younger than 70 years was higher (67%) than among people aged 70 years and above (33%). YLL among people aged 70 years and above, contributed to 74% of the total YLL.</AbstractText><AbstractText Label="CONCLUSIONS">COVID-19 had a substantial impact on population health in France in 2020. The majority of population health loss was due to mortality. Men had higher population health loss due to COVID-19 than women. Post-acute consequences of COVID-19 had a large contribution to the YLD component of the disease burden, even when we assume the shortest duration of 28 days, long COVID burden is large. Further research is recommended to assess the impact of health inequalities associated with these estimates.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Haneef et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haneef</LastName><ForeName>Romana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7741-0268</Identifier><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fayad</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Data science, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fouillet</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Data science, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommen</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Data science, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonaldi</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8939-6205</Identifier><AffiliationInfo><Affiliation>Department of Data science, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyper</LastName><ForeName>Grant M A</ForeName><Initials>GMA</Initials><Identifier Source="ORCID">0000-0003-2854-5822</Identifier><AffiliationInfo><Affiliation>School of Health &amp; Wellbeing, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pires</LastName><ForeName>Sara Monteiro</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>National Food Institute, Technical University of Denmark, Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devleesschauwer</LastName><ForeName>Brecht</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rachas</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9226-9071</Identifier><AffiliationInfo><Affiliation>Department of Strategy, Studies and Statistics, French National Health Insurance: Caisse nationale de l'assurance maladie (Cnam), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constantinou</LastName><ForeName>Panayotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Strategy, Studies and Statistics, French National Health Insurance: Caisse nationale de l'assurance maladie (Cnam), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy-Bruhl</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltzer</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallay</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087509" MajorTopicYN="N">Disability-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006233" MajorTopicYN="Y">Disabled Persons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: Romana Haneef is the first and corresponding author of this paper, and is the section editor of &#x201c;health information system&#x201d; of &#x201c;Archives of Public Health&#x201d;. Brecht Devleesschauwer is one of the co-authors of this paper, and is academic editor at PLOS ONE and the guest editor of the article collection on &#x201c;burden of disease&#x201d; of &#x201c;Archives of Public Health&#x201d;. All other authors declare that they have no competing interests related to the work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36693071</ArticleId><ArticleId IdType="pmc">PMC9873186</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0280990</ArticleId><ArticleId IdType="pii">PONE-D-22-11149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157&#x2013;60. doi: 10.23750/abm.v91i1.9397</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al.. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Eurosurveillance. 2020;25(6):2000094. doi: 10.2807/1560-7917.ES.2020.25.6.2000094</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.6.2000094</ArticleId><ArticleId IdType="pmc">PMC7029452</ArticleId><ArticleId IdType="pubmed">32070465</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaux S, Blondel C, Platon J, et al.. Vaccine Coverage Against COVID-19 and Impact on the Dynamics of the Epidemic: http://beh.santepubliquefrance.fr/beh/2021/cov_12/pdf/2021_Cov_12_1.pdf. 2021.</Citation></Reference><Reference><Citation>Cauchemez S, Kiem CT, Paireau J, Rolland P, Fontanet A. Lockdown impact on COVID-19 epidemics in regions across metropolitan France. The Lancet. 2020;396(10257):1068&#x2013;9. doi: 10.1016/S0140-6736(20)32034-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32034-1</ArticleId><ArticleId IdType="pmc">PMC7524515</ArticleId><ArticleId IdType="pubmed">33007219</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaccaferri G, Larrieu S, Pouey J, Calba C, Benet T, Sommen C, et al.. Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020. Eurosurveillance. 2020;25(50):2001974. doi: 10.2807/1560-7917.ES.2020.25.50.2001974</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.50.2001974</ArticleId><ArticleId IdType="pmc">PMC7812421</ArticleId><ArticleId IdType="pubmed">33334399</ArticleId></ArticleIdList></Reference><Reference><Citation>Devleesschauwer B, Maertens de Noordhout C, Smit GSA, Duchateau L, Dorny P, Stein C, et al.. Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints. BMC Public Health. 2014;14(1):1196. doi: 10.1186/1471-2458-14-1196</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-1196</ArticleId><ArticleId IdType="pmc">PMC4246467</ArticleId><ArticleId IdType="pubmed">25416547</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJL, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al.. GBD 2010: design, definitions, and metrics. The Lancet. 2012;380(9859):2063&#x2013;6. doi: 10.1016/S0140-6736(12)61899-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61899-6</ArticleId><ArticleId IdType="pubmed">23245602</ArticleId></ArticleIdList></Reference><Reference><Citation>Haneef R, Schmidt J, Gallay A, Devleesschauwer B, Grant I, Rommel A, et al.. Recommendations to plan a national burden of disease study. Archives of Public Health. 2021;79(1):126. doi: 10.1186/s13690-021-00652-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-021-00652-x</ArticleId><ArticleId IdType="pmc">PMC8262070</ArticleId><ArticleId IdType="pubmed">34233754</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas M, Katikireddi SV, Taulbut M, McKee M, McCartney G. Mitigating the wider health effects of covid-19 pandemic response. BMJ. 2020;369:m1557. doi: 10.1136/bmj.m1557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1557</ArticleId><ArticleId IdType="pmc">PMC7184317</ArticleId><ArticleId IdType="pubmed">32341002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyper GMA, Assun&#xe7;&#xe3;o RMA, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al.. Burden of Disease Methods: A Guide to Calculate COVID-19 Disability-Adjusted Life Years. International Journal of Public Health. 2021;66. doi: 10.3389/ijph.2021.619011</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2021.619011</ArticleId><ArticleId IdType="pmc">PMC8565264</ArticleId><ArticleId IdType="pubmed">34744580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameli.fr. SI-DEP(Syst&#xe8;me d&#x2019;Information de DEpistage Poulationnel): https://www.ameli.fr/assure/covid-19/tester-alerter-proteger-comprendre-la-strategie-pour-stopper-l-epidemie/contact-covid-et-si-dep-des-outils-au-service-du-depistage. 2020.</Citation></Reference><Reference><Citation>ANS. SI-VIC (Syst&#xe8;me d&#x2019;Identification unique des VICtimes d&#xe9;nomm&#xe9;): https://esante.gouv.fr/SI-VIC. 2016.</Citation></Reference><Reference><Citation>Wyper GM, Assun&#xe7;&#xe3;o RM, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al.. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years:
https://osf.io/preprints/socarxiv/tazyh/. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8565264</ArticleId><ArticleId IdType="pubmed">34744580</ArticleId></ArticleIdList></Reference><Reference><Citation>James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&#x2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789&#x2013;858. doi: 10.1016/S0140-6736(18)32279-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32279-7</ArticleId><ArticleId IdType="pmc">PMC6227754</ArticleId><ArticleId IdType="pubmed">30496104</ArticleId></ArticleIdList></Reference><Reference><Citation>SPF. Sant&#xe9; Publique France: Conduite &#xe0; tenir devant un cas possible d&#x2019;infection au SARS-CoV-2 (COVID-19) 2021.</Citation></Reference><Reference><Citation>McDonald SA, Lagerweij G, Boer Pd, Melker HE, Pijnacker R, Gras LM, et al.. The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years: https://www.researchsquare.com/article/rs-1026794/v1. Preprint. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366822</ArticleId><ArticleId IdType="pubmed">35951278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nature Medicine. 2021;27(4):626&#x2013;31. doi: 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, et al.. Assessing disability weights based on the responses of 30,660 people from four European countries. Population Health Metrics. 2015;13(1):10. doi: 10.1186/s12963-015-0042-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12963-015-0042-4</ArticleId><ArticleId IdType="pmc">PMC4715333</ArticleId><ArticleId IdType="pubmed">26778920</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al.. Disability weights for the Global Burden of Disease 2013 study. The Lancet Global Health. 2015;3(11):e712&#x2013;e23. doi: 10.1016/S2214-109X(15)00069-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(15)00069-8</ArticleId><ArticleId IdType="pubmed">26475018</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe9;piDC: https://www.cepidc.inserm.fr/qui-sommes-nous/le-cepidc.</Citation></Reference><Reference><Citation>WHO. Iris automated coding system for causes of death: https://score.tools.who.int/tools/count-births-deaths-and-causes-of-death/tool/iris-automated-coding-system-for-causes-of-death-97/.</Citation></Reference><Reference><Citation>WHO. Emergency use ICD codes for COVID-19 disease outbreak: https://www.who.int/standards/classifications/classification-of-diseases/emergency-use-icd-codes-for-covid-19-disease-outbreak. 2020.</Citation></Reference><Reference><Citation>IHME. Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table: https://ghdx.healthdata.org/record/ihme-data/global-burden-disease-study-2019-gbd-2019-reference-life-table. 2019.</Citation></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al.. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. Journal of Infection. 2021;82(3):378&#x2013;83. doi: 10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G, Newcomb R, Cowl CT, Murad MH, Breeher L, Miller S, et al.. Post&#x2013;COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clinic Proceedings. 2021;96(7):1782&#x2013;91. doi: 10.1016/j.mayocp.2021.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, Marks M, Livingston R, Ridsdale HA, et al.. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respiratory Research. 2021;8(1):e001041. doi: 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MP. Estimating total morbidity burden of COVID-19: relative importance of death and disability. Journal of Clinical Epidemiology. 2022;142:54&#x2013;9. doi: 10.1016/j.jclinepi.2021.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.10.018</ArticleId><ArticleId IdType="pmc">PMC8547965</ArticleId><ArticleId IdType="pubmed">34715312</ArticleId></ArticleIdList></Reference><Reference><Citation>Rommel A, Lippe EV, Plass D, Ziese T, Diercke M, Heiden MA, et al.. The COVID-19 Disease Burden in Germany in 2020. Dtsch Arztebl Int. 2021;118(9):145&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212397</ArticleId><ArticleId IdType="pubmed">33958032</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyper GMA, Fletcher E, Grant I, Harding O, de Haro Moro MT, Stockton DL, et al.. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. International Journal for Equity in Health. 2021;20(1):214. doi: 10.1186/s12939-021-01547-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01547-7</ArticleId><ArticleId IdType="pmc">PMC8474788</ArticleId><ArticleId IdType="pubmed">34565406</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health. 2021;21(1):1827. doi: 10.1186/s12889-021-11893-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11893-4</ArticleId><ArticleId IdType="pmc">PMC8501913</ArticleId><ArticleId IdType="pubmed">34627228</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran DP, Pires SM, Wyper GMA, Devleesschauwer B, Cuschieri S, Kabir Z. Estimating the Direct Disability-Adjusted Life Years Associated With SARS-CoV-2 (COVID-19) in the Republic of Ireland: The First Full Year. International Journal of Public Health. 2022;67. doi: 10.3389/ijph.2022.1604699</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2022.1604699</ArticleId><ArticleId IdType="pmc">PMC9200950</ArticleId><ArticleId IdType="pubmed">35719731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires SM, Redondo HG, Espenhain L, Jakobsen LS, Legarth R, Meaidi M, et al.. Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic. BMC Public Health. 2022;22(1):1315. doi: 10.1186/s12889-022-13694-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13694-9</ArticleId><ArticleId IdType="pmc">PMC9270752</ArticleId><ArticleId IdType="pubmed">35804310</ArticleId></ArticleIdList></Reference><Reference><Citation>AIHW. The first year of COVID-19 in Australia: direct and indirect health effects:
https://www.aihw.gov.au/getmedia/a69ee08a-857f-412b-b617-a29acb66a475/aihw-phe-287.pdf.aspx?inline=true. 2021.</Citation></Reference><Reference><Citation>Devleesschauwer B, McDonald SA, Speybroeck N, Wyper GMA. Valuing the years of life lost due to COVID-19: the differences and pitfalls. International Journal of Public Health. 2020;65(6):719&#x2013;20. doi: 10.1007/s00038-020-01430-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-020-01430-2</ArticleId><ArticleId IdType="pmc">PMC7370635</ArticleId><ArticleId IdType="pubmed">32691080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullano G, Di Domenico L, Sabbatini CE, Valdano E, Turbelin C, Debin M, et al.. Underdetection of cases of COVID-19 in France threatens epidemic control. Nature. 2021;590(7844):134&#x2013;9. doi: 10.1038/s41586-020-03095-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03095-6</ArticleId><ArticleId IdType="pubmed">33348340</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, et al.. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343. doi: 10.1136/bmjopen-2020-045343</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045343</ArticleId><ArticleId IdType="pmc">PMC7969768</ArticleId><ArticleId IdType="pubmed">33727273</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al.. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders. 2020;277:55&#x2013;64. doi: 10.1016/j.jad.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7413844</ArticleId><ArticleId IdType="pubmed">32799105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. Journal of epidemiology and community health. 2020;74(11):964&#x2013;8. doi: 10.1136/jech-2020-214401</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2020-214401</ArticleId><ArticleId IdType="pmc">PMC7298201</ArticleId><ArticleId IdType="pubmed">32535550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al.. Post-acute COVID-19 syndrome. Nature Medicine. 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Group ftGAC-P-ACS. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al.. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. Journal of Medical Virology. 2021;93(2):1013&#x2013;22. doi: 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al.. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection. 2021;27(2):258&#x2013;63. doi: 10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al.. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al.. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine. 2020;174(4):576&#x2013;8. doi: 10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>